| 211 | Humans |
| 208 | Coronavirus Infections |
| 206 | Pneumonia, Viral |
| 152 | Betacoronavirus |
| 91 | China |
| 68 | Disease Outbreaks |
| 34 | Male |
| 32 | Female |
| 31 | Animals |
| 31 | Adult |
| 30 | Travel |
| 30 | Pandemics |
| 26 | Middle Aged |
| 20 | Severe Acute Respiratory Syndrome |
| 19 | SARS Virus |
| 18 | Public Health |
| 18 | Phylogeny |
| 18 | Lung |
| 18 | Genome, Viral |
| 15 | Zoonoses |
| 15 | Antiviral Agents |
| 14 | Tomography, X-Ray Computed |
| 14 | Fever |
| 13 | Young Adult |
| 13 | Coronavirus |
| 13 | Aged |
| 12 | Communicable Diseases, Emerging |
| 12 | Chiroptera |
| 12 | Child |
| 11 | United States |
| 11 | Infection Control |
| 11 | Cough |
| 10 | Risk Factors |
| 10 | Republic of Korea |
| 10 | Middle East Respiratory Syndrome Coronavirus |
| 9 | Spike Glycoprotein, Coronavirus |
| 9 | Retrospective Studies |
| 9 | Global Health |
| 8 | World Health Organization |
| 8 | Severity of Illness Index |
| 8 | Radiography, Thoracic |
| 8 | Europe |
| 8 | Epidemics |
| 7 | Real-Time Polymerase Chain Reaction |
| 7 | Quarantine |
| 7 | Population Surveillance |
| 7 | Peptidyl-Dipeptidase A |
| 7 | Patient Isolation |
| 7 | Health Personnel |
| 7 | Adolescent |
| 6 | Respiration, Artificial |
| 6 | Models, Theoretical |
| 6 | Mass Screening |
| 6 | Infant |
| 6 | Dyspnea |
| 6 | Disease Progression |
| 5 | Viral Vaccines |
| 5 | Risk Assessment |
| 5 | Receptors, Virus |
| 5 | RNA, Viral |
| 5 | Influenza, Human |
| 5 | Infectious Disease Transmission, Patient-to-Professional |
| 5 | Forecasting |
| 5 | Disease Reservoirs |
| 5 | Critical Care |
| 5 | Communication |
| 5 | Biomedical Research |
| 5 | Amino Acid Sequence |
| 5 | Air Travel |
| 5 | Aged, 80 and over |
| 4 | Viral Proteins |
| 4 | United Kingdom |
| 4 | Travel Medicine |
| 4 | Ritonavir |
| 4 | Respiratory Tract Infections |
| 4 | Respiratory Insufficiency |
| 4 | Respiratory Distress Syndrome, Adult |
| 4 | Practice Guidelines as Topic |
| 4 | Lopinavir |
| 4 | Infectious Disease Incubation Period |
| 4 | Infant, Newborn |
| 4 | Drugs, Chinese Herbal |
| 4 | Drug Evaluation, Preclinical |
| 4 | Disease Transmission, Infectious |
| 4 | Disaster Planning |
| 4 | Delivery of Health Care |
| 4 | Cross Infection |
| 4 | Critical Illness |
| 4 | Contact Tracing |
| 4 | Communicable Disease Control |
| 4 | Colorectal Neoplasms |
| 4 | Clinical Trials as Topic |
| 4 | Biomarkers |
| 4 | Basic Reproduction Number |
| 4 | Asymptomatic Infections |
| 4 | Antibodies, Viral |
| 4 | Antibodies, Monoclonal |
| 3 | Virus Replication |
| 3 | Virus Diseases |
| 3 | Universities |
| 3 | Time Factors |
| 3 | Social Media |
| 3 | Sequence Alignment |
| 3 | Seasons |
| 3 | Research |
| 3 | Public Health Surveillance |
| 3 | Prognosis |
| 3 | Mortality |
| 3 | Models, Genetic |
| 3 | Mental Health Services |
| 3 | Melia azedarach |
| 3 | Medical History Taking |
| 3 | Masks |
| 3 | Internationality |
| 3 | International Cooperation |
| 3 | Intensive Care Units |
| 3 | Information Dissemination |
| 3 | Hygiene |
| 3 | Host Specificity |
| 3 | Hospitalization |
| 3 | Health Services Accessibility |
| 3 | Fatigue |
| 3 | Family Health |
| 3 | Emigration and Immigration |
| 3 | Emergencies |
| 3 | Drug Repositioning |
| 3 | Drug Discovery |
| 3 | Drug Design |
| 3 | Drug Combinations |
| 3 | Disease Susceptibility |
| 3 | Diagnosis, Differential |
| 3 | Civil Defense |
| 3 | Child, Preschool |
| 3 | Anxiety |
| 3 | Antibodies, Neutralizing |
| 3 | Alanine |
| 2 | Whole Genome Sequencing |
| 2 | Vulnerable Populations |
| 2 | Virus Shedding |
| 2 | Virus Attachment |
| 2 | Viral Nonstructural Proteins |
| 2 | Viral Load |
| 2 | Vero Cells |
| 2 | Uncertainty |
| 2 | Transportation |
| 2 | Thailand |
| 2 | Taiwan |
| 2 | Social Conditions |
| 2 | Singapore |
| 2 | Ships |
| 2 | Sex Distribution |
| 2 | Sequence Analysis, Protein |
| 2 | Science |
| 2 | Rural Population |
| 2 | Risk |
| 2 | Respiratory Sounds |
| 2 | Recombination, Genetic |
| 2 | Recombinant Proteins |
| 2 | Racism |
| 2 | Public Health Practice |
| 2 | Prevalence |
| 2 | Predictive Value of Tests |
| 2 | Pharynx |
| 2 | Personal Protective Equipment |
| 2 | Periodicals as Topic |
| 2 | Patient Safety |
| 2 | Patient Education as Topic |
| 2 | Patient Discharge |
| 2 | Occupational Exposure |
| 2 | Nucleosides |
| 2 | Nucleic Acid Amplification Techniques |
| 2 | Noninvasive Ventilation |
| 2 | Myalgia |
| 2 | Mutation Rate |
| 2 | Molecular Diagnostic Techniques |
| 2 | Models, Statistical |
| 2 | Models, Molecular |
| 2 | Microbial Viability |
| 2 | Mental Health |
| 2 | Macau |
| 2 | Leukocyte Count |
| 2 | Latin America |
| 2 | Japan |
| 2 | Intensive Care Units, Neonatal |
| 2 | Inpatients |
| 2 | Incidence |
| 2 | Immunity |
| 2 | Host-Pathogen Interactions |
| 2 | Hospitals |
| 2 | Hospitals, Psychiatric |
| 2 | Health Workforce |
| 2 | Health Policy |
| 2 | Guidelines as Topic |
| 2 | Genetic Variation |
| 2 | Feces |
| 2 | Evolution, Molecular |
| 2 | Evidence-Based Medicine |
| 2 | Epidemiological Monitoring |
| 2 | Decision Making |
| 2 | Databases, Genetic |
| 2 | Cysteine Endopeptidases |
| 2 | Consensus |
| 2 | Comorbidity |
| 2 | Cluster Analysis |
| 2 | Chlorocebus aethiops |
| 2 | Cell Line |
| 2 | Brazil |
| 2 | Blood Chemical Analysis |
| 2 | Base Sequence |
| 2 | Australia |
| 2 | Asymptomatic Diseases |
| 2 | Age Factors |
| 2 | Age Distribution |
| 2 | Adrenal Cortex Hormones |
| 2 | Adenosine Monophosphate |
| 2 | Adaptation, Psychological |
| 2 | Access to Information |
| 1 | Zika Virus |
| 1 | Zika Virus Infection |
| 1 | Xenophobia |
| 1 | Writing |
| 1 | Web Browser |
| 1 | Weather |
| 1 | Waste Management |
| 1 | Virus Physiological Phenomena |
| 1 | Virulence |
| 1 | Virology |
| 1 | Viral Tropism |
| 1 | Viral Structural Proteins |
| 1 | Vaccination |
| 1 | Triage |
| 1 | Treatment Outcome |
| 1 | Teaching |
| 1 | Switzerland |
| 1 | Surveys and Questionnaires |
| 1 | Students |
| 1 | Stress, Psychological |
| 1 | State Medicine |
| 1 | Spouses |
| 1 | Solubility |
| 1 | Societies, Medical |
| 1 | Social Support |
| 1 | Social Stigma |
| 1 | Social Isolation |
| 1 | Social Distance |
| 1 | Social Discrimination |
| 1 | Social Capital |
| 1 | Snakes |
| 1 | Small Molecule Libraries |
| 1 | Sleep |
| 1 | Sleep Wake Disorders |
| 1 | Sincalide |
| 1 | Sign Language |
| 1 | Serum Albumin |
| 1 | Sequence Homology, Nucleic Acid |
| 1 | Sequence Analysis, DNA |
| 1 | Sensitivity and Specificity |
| 1 | Security Measures |
| 1 | Search Engine |
| 1 | Schools |
| 1 | Saudi Arabia |
| 1 | Salmonella |
| 1 | Risk Management |
| 1 | Ribonucleotides |
| 1 | Reverse Transcriptase Polymerase Chain Reaction |
| 1 | Respiratory System |
| 1 | Respiratory Mechanics |
| 1 | Research Personnel |
| 1 | Reproducibility of Results |
| 1 | Rehabilitation |
| 1 | Receptors, Interleukin-2 |
| 1 | Receptor, Angiotensin, Type 2 |
| 1 | Radiologists |
| 1 | Radiography |
| 1 | ROC Curve |
| 1 | RNA Replicase |
| 1 | Qualitative Research |
| 1 | Public Policy |
| 1 | Proteome |
| 1 | Protein Structure, Tertiary |
| 1 | Protein Structure, Quaternary |
| 1 | Protein Domains |
| 1 | Protein Conformation |
| 1 | Protein Binding |
| 1 | Protective Clothing |
| 1 | Protease Inhibitors |
| 1 | Prospective Studies |
| 1 | Problem Solving |
| 1 | Prejudice |
| 1 | Pregnancy |
| 1 | Pregnancy Outcome |
| 1 | Pregnancy Complications, Infectious |
| 1 | Polysaccharides |
| 1 | Polymerase Chain Reaction |
| 1 | Polyethylene Glycols |
| 1 | Political Activism |
| 1 | Pneumonia |
| 1 | Plasma |
| 1 | Placenta |
| 1 | Pharmacists |
| 1 | Patient Selection |
| 1 | Patient Care |
| 1 | Patient Care Planning |
| 1 | Patient Advocacy |
| 1 | Paramyxoviridae Infections |
| 1 | Panic |
| 1 | Outpatients |
| 1 | Oseltamivir |
| 1 | Oropharynx |
| 1 | Operations Research |
| 1 | Oligonucleotides |
| 1 | Nursing Care |
| 1 | Nucleocapsid Proteins |
| 1 | Nose |
| 1 | Nigeria |
| 1 | Neuraminidase |
| 1 | Neoplasms |
| 1 | National Institutes of Health (U.S.) |
| 1 | National Health Programs |
| 1 | Nasopharynx |
| 1 | Naja naja |
| 1 | Myocardium |
| 1 | Mouth |
| 1 | Molecular Targeted Therapy |
| 1 | Molecular Epidemiology |
| 1 | Models, Chemical |
| 1 | Models, Animal |
| 1 | Microscopy, Electron, Transmission |
| 1 | Mice |
| 1 | Metapneumovirus |
| 1 | Mental Disorders |
| 1 | Mediterranean Region |
| 1 | Medicine, Chinese Traditional |
| 1 | Medical Waste |
| 1 | Medical Waste Disposal |
| 1 | Maternal Exposure |
| 1 | Massage |
| 1 | Mammals |
| 1 | Malaria |
| 1 | Macrolides |
| 1 | Machine Learning |
| 1 | Lymphocyte Count |
| 1 | Lung Neoplasms |
| 1 | Lung Injury |
| 1 | Livestock |
| 1 | Liver |
| 1 | Lipids |
| 1 | Likelihood Functions |
| 1 | Laparoscopy |
| 1 | Laboratories |
| 1 | Italy |
| 1 | Interviews as Topic |
| 1 | Interprofessional Relations |
| 1 | Interpersonal Relations |
| 1 | Internet |
| 1 | Interleukin-6 |
| 1 | Interinstitutional Relations |
| 1 | Interferons |
| 1 | Interferon-beta |
| 1 | Interferon-alpha |
| 1 | Interatrial Block |
| 1 | Integrative Oncology |
| 1 | Influenza A virus |
| 1 | Infectious Disease Transmission, Vertical |
| 1 | Indoles |
| 1 | Immune Sera |
| 1 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| 1 | Hydroxychloroquine |
| 1 | Hospitals, Private |
| 1 | Hong Kong |
| 1 | Homologous Recombination |
| 1 | Holidays |
| 1 | High-Throughput Nucleotide Sequencing |
| 1 | Heterocyclic Compounds, 4 or More Rings |
| 1 | Hepatitis C |
| 1 | Hepatitis B |
| 1 | Health Status Disparities |
| 1 | Health Planning |
| 1 | Health Knowledge, Attitudes, Practice |
| 1 | Health Behavior |
| 1 | Headache |
| 1 | Haplorhini |
| 1 | HIV-1 |
| 1 | HIV Infections |
| 1 | Government |
| 1 | Germany |
| 1 | Genomics |
| 1 | Genetic Engineering |
| 1 | General Surgery |
| 1 | Fluorenes |
| 1 | Fluid Therapy |
| 1 | Financing, Government |
| 1 | Fibrin Fibrinogen Degradation Products |
| 1 | Feasibility Studies |
| 1 | Fear |
| 1 | Family Characteristics |
| 1 | False Negative Reactions |
| 1 | Faculty |
| 1 | Extracorporeal Membrane Oxygenation |
| 1 | Eutheria |
| 1 | Equipment and Supplies, Hospital |
| 1 | Epitopes |
| 1 | Epidemiologic Studies |
| 1 | Environmental Microbiology |
| 1 | Environmental Exposure |
| 1 | Endoscopy, Gastrointestinal |
| 1 | Emergency Service, Hospital |
| 1 | Emergency Medical Services |
| 1 | Education, Distance |
| 1 | Editorial Policies |
| 1 | Early Diagnosis |
| 1 | Early Detection of Cancer |
| 1 | Drug Therapy |
| 1 | Disinfectants |
| 1 | Disease Vectors |
| 1 | Disease Models, Animal |
| 1 | Dipeptidyl Peptidase 4 |
| 1 | Diarrhea |
| 1 | Diagnostic Errors |
| 1 | Developing Countries |
| 1 | Dermatology |
| 1 | Depression |
| 1 | Dentists |
| 1 | Dental Clinics |
| 1 | Dental Care |
| 1 | Dengue |
| 1 | Deep Learning |
| 1 | Decision Support Techniques |
| 1 | Deafness |
| 1 | Datasets as Topic |
| 1 | Data Collection |
| 1 | Data Analysis |
| 1 | DNA, Viral |
| 1 | Cytokines |
| 1 | Cytochrome P-450 CYP3A Inhibitors |
| 1 | Cross-Sectional Studies |
| 1 | Cross Reactions |
| 1 | Counseling |
| 1 | Correlation of Data |
| 1 | Cooperative Behavior |
| 1 | Consumer Health Information |
| 1 | Compassionate Use Trials |
| 1 | Community-Acquired Infections |
| 1 | Community Pharmacy Services |
| 1 | Community Health Services |
| 1 | Commerce |
| 1 | Colorectal Surgery |
| 1 | Coinfection |
| 1 | Codon Usage |
| 1 | Cities |
| 1 | Chloroquine |
| 1 | Chemotherapy, Adjuvant |
| 1 | Centers for Disease Control and Prevention, U.S. |
| 1 | Cardiovascular Surgical Procedures |
| 1 | Carbamates |
| 1 | Bungarus |
| 1 | Bronchoscopy |
| 1 | Bronchoalveolar Lavage Fluid |
| 1 | Body Temperature |
| 1 | Body Mass Index |
| 1 | Biomedical Technology |
| 1 | Biological Assay |
| 1 | Binding Sites |
| 1 | Benzimidazoles |
| 1 | Beijing |
| 1 | Bed Occupancy |
| 1 | Bayes Theorem |
| 1 | Automobiles |
| 1 | Asian Continental Ancestry Group |
| 1 | Artificial Intelligence |
| 1 | Aortic Aneurysm |
| 1 | Antineoplastic Combined Chemotherapy Protocols |
| 1 | Antimalarials |
| 1 | Anti-Inflammatory Agents |
| 1 | Anti-Inflammatory Agents, Non-Steroidal |
| 1 | Anti-HIV Agents |
| 1 | Anti-Bacterial Agents |
| 1 | Anopheles |
| 1 | Anniversaries and Special Events |
| 1 | Animals, Wild |
| 1 | Angiotensin II |
| 1 | Angiotensin II Type 2 Receptor Blockers |
| 1 | Aneurysm, Dissecting |
| 1 | Alphacoronavirus |
| 1 | Algorithms |
| 1 | Aircraft |
| 1 | Air Microbiology |
| 1 | Aedes |
| 1 | Administration, Inhalation |
| 1 | Acupuncture Therapy |
| 1 | Academies and Institutes |
